Back

Medscape, LLC

  • Antipsychotic Agents
  • Injections
  • Schizophrenia

Integrating Long-Acting Injectables Earlier in Schizophrenia Care

The goal of this activity is for learners to be better able to have knowledge of the evidence in support of using LAIs earlier in the treatment of schizophrenia and improve their ability to apply patient-centered communication strategies to engage patients in shared decision-making regarding long-acting injectable antipsychotic therapy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    Jun 24, 2026
  • Last day to claim credit
    Jun 25, 2027 9 months left